Business Description
Polynovo Ltd
NAICS : 325413
SIC : 2835
ISIN : AU000000PNV0
Description
Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.99 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.21 | |||||
| Debt-to-EBITDA | 3.8 | |||||
| Interest Coverage | 8.25 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 28.89 | |||||
| Beneish M-Score | -1.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 49.5 | |||||
| 3-Year Book Growth Rate | 45.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 94.28 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 25.59 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.68 | |||||
| 9-Day RSI | 49.39 | |||||
| 14-Day RSI | 50.55 | |||||
| 6-1 Month Momentum % | 3.27 | |||||
| 12-1 Month Momentum % | 50.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.41 | |||||
| Quick Ratio | 3.03 | |||||
| Cash Ratio | 1.98 | |||||
| Days Inventory | 452.78 | |||||
| Days Sales Outstanding | 57.81 | |||||
| Days Payable | 435.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | 0.09 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 94.69 | |||||
| Operating Margin % | 1.13 | |||||
| Net Margin % | 5.1 | |||||
| FCF Margin % | 0.76 | |||||
| ROE % | 7.64 | |||||
| ROA % | 5.29 | |||||
| ROIC % | 8.78 | |||||
| 3-Year ROIIC % | 36.12 | |||||
| ROC (Joel Greenblatt) % | 5.41 | |||||
| ROCE % | 2.23 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 324 | |||||
| Forward PE Ratio | 180 | |||||
| PE Ratio without NRI | 324 | |||||
| Price-to-Owner-Earnings | 311.73 | |||||
| PS Ratio | 16.97 | |||||
| PB Ratio | 27 | |||||
| Price-to-Tangible-Book | 27 | |||||
| Price-to-Free-Cash-Flow | 2493.82 | |||||
| Price-to-Operating-Cash-Flow | 498.76 | |||||
| EV-to-EBIT | 931.4 | |||||
| EV-to-EBITDA | 426.19 | |||||
| EV-to-Revenue | 16.73 | |||||
| EV-to-Forward-Revenue | 9.04 | |||||
| EV-to-FCF | 2193.1 | |||||
| Price-to-Graham-Number | 18 | |||||
| Price-to-Net-Current-Asset-Value | 40.5 | |||||
| Price-to-Net-Cash | 162 | |||||
| Earnings Yield (Greenblatt) % | 0.11 | |||||
| FCF Yield % | 0.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CALZF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Polynovo Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 68.772 | ||
| EPS (TTM) ($) | 0.005 | ||
| Beta | 1.01 | ||
| Volatility % | 93.38 | ||
| 14-Day RSI | 50.55 | ||
| 14-Day ATR ($) | 0.02443 | ||
| 20-Day SMA ($) | 1.635405 | ||
| 12-1 Month Momentum % | 50.48 | ||
| 52-Week Range ($) | 0.513 - 1.74 | ||
| Shares Outstanding (Mil) | 690.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Polynovo Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Polynovo Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Polynovo Ltd Frequently Asked Questions
What is Polynovo Ltd(CALZF)'s stock price today?
The current price of CALZF is $1.62. The 52 week high of CALZF is $1.74 and 52 week low is $0.51.
When is next earnings date of Polynovo Ltd(CALZF)?
The next earnings date of Polynovo Ltd(CALZF) is 2024-11-29 Est..
Does Polynovo Ltd(CALZF) pay dividends? If so, how much?
Polynovo Ltd(CALZF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers